Patent directory · USPTO A61K / A61P
Patents matching “SION”
1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11384337
Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 11382922
Aqueous oral pharmaceutical suspension compositions
granted -
US 11376273
Modulation of factor 11 expression
granted -
US 11365416
Modulators of EZH2 expression
granted -
US 11357841
Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof
granted -
US 11351190
Composition for treating tissue lesions
granted -
US 11352402
Interleukin-4 receptor-binding fusion proteins and uses thereof
granted -
US 11352639
Gene therapy based on vector VTVAF17
granted -
US 11351118
Methods for ameliorating infusion reactions
granted -
US 11345733
Colon and pancreas cancer specific antigens and antibodies
granted -
US 11345904
Targeted therapeutic lysosomal enzyme fusion proteins, associated formulations and uses thereof
granted -
US 11345894
Cellular seeding and co-culture of a three dimensional fibroblast construct
granted -
US 11344577
Car+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA
granted -
US 11344631
Promoter for cell-specific gene expression and uses thereof
granted -
US 11345658
Compounds and compositions comprising the same for treating hypertension or heart failure
granted -
US 11339393
Compositions for modulating C9ORF72 expression
granted -
US 11339198
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
granted -
US 11332746
Compounds and methods for reducing LRRK2 expression
granted -
US 11324760
Solid dispersion of dutasteride, method for preparing the solid dispersion, and pharmaceutical composition including the solid dispersion
granted -
US 11319536
Modulating apolipoprotein (a) expression
granted -
US 11317888
Non-invasive method for pressure measurement
granted -
US 11312964
Compositions and methods for modulating growth hormone receptor expression
granted -
US 11291659
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
granted -
US 11293025
Compositions and methods for modulating Ataxin 3 expression
granted